Description

Diphenoxylate & Atropine Sulfate Tablets 

Healthy Inc is a specialized global supplier and exporter of advanced gastroenterology, acute care, and targeted high-containment anti-diarrheal therapeutics. We provide ultra-high-purity, kinetically synchronized Diphenoxylate Hydrochloride & Atropine Sulfate Tablets (2.5 mg / 0.025 mg), manufactured in WHO–GMP certified, highly regulated, micro-dosing oral solid dosage facilities. This “Opioid-Receptor Agonist & Abuse-Deterrent FDC” is a highly strategic, controlled-volume export to gastroenterology networks, acute infectious disease wards, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, rapid-onset intervention for severe, debilitating acute and chronic diarrhea.

Product Overview

This highly advanced formulation operates as a profound, mechanical brake for the gastrointestinal tract. It chemically commands the hyperactive intestines to stop spasming and slow down, allowing the body to reabsorb critical water and electrolytes before the patient suffers fatal dehydration.

The “Mu-Opioid Gut Paralyzer & Anticholinergic Shield” Specialist:

• Mechanism 1 (The Peristaltic Brake – Diphenoxylate): Diphenoxylate is a synthetic phenylpiperidine opioid derivative. It binds aggressively to peripheral mu-opioid receptors located within the smooth muscle of the intestinal wall. This violently inhibits excessive GI motility and propulsion (peristalsis), increasing intestinal transit time. The delayed transit allows the gut lining to reabsorb massive amounts of fluid, instantly transforming watery, life-threatening diarrhea into formed, manageable stools.
• Mechanism 2 (The Abuse-Deterrent Shield – Atropine): Because Diphenoxylate is an opioid, massive doses can cross the blood-brain barrier to produce a euphoric “high.” To prevent addiction and overdose, the formulation integrates a sub-therapeutic dose of Atropine Sulfate. If a patient attempts to abuse the drug by taking handfuls of pills, the accumulated Atropine triggers a terrifying, highly aversive anticholinergic crisis (extreme dry mouth, blinding tachycardia, blurred vision, and urinary retention). This strictly prevents recreational abuse.
• The “Blood-Brain Barrier” Polarity: At standard therapeutic doses (2.5 mg to 5 mg), Diphenoxylate is highly localized to the gut and produces virtually zero central nervous system (CNS) analgesia or euphoria, making it an exceptionally effective, non-intoxicating clinical tool when used correctly.

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Gastroenterology Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Extreme Microdose Content Uniformity (CRITICAL COMPLIANCE): The engineering challenge of this FDC defines its global safety. Standard generic manufacturers struggle to blend a 0.025 mg (25 microgram) active ingredient evenly. If Content Uniformity fails, a patient could ingest a massive, accidental overdose of Atropine, instantly triggering a fatal anticholinergic crisis (tachycardia, hyperthermia, seizures). Our specialized GI suites utilize elite geometric dry-blending and intensive HPLC batch-testing to guarantee 100% uniformity, proving to major health ministries that our formulations are clinically flawless.

Therapeutic Indications (Human Use)

Indicated for the targeted, rapid management of severe gastrointestinal hypermotility:

• Acute Diarrhea: Adjunctive therapy in the management of severe, debilitating acute diarrhea to prevent catastrophic fluid loss.
• Chronic Diarrhea: Management of chronic diarrhea associated with inflammatory bowel disease (when clinically appropriate) or post-surgical short bowel syndrome.

Dosage & Administration

Recommended Dosage (Strictly as per Physician Guidelines):

• Standard Adult Dosing: Initially, 2 tablets taken 4 times daily (maximum 20 mg Diphenoxylate per day) until initial control is achieved, then rapidly tapered down to a maintenance dose.
• Clinical Efficacy Timeline: Clinical improvement of acute diarrhea is usually observed within 48 hours. If clinical improvement is not seen within 10 days, the drug is unlikely to be effective and must be discontinued.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• Infectious Diarrhea Contraindication (FATAL WARNING): Strictly contraindicated in patients suffering from diarrhea caused by enterotoxin-producing bacteria (like C. difficile, Salmonella, or Shigella). By paralyzing the gut, the drug traps the lethal bacteria and their toxins inside the body, potentially causing toxic megacolon, sepsis, and death.
• Respiratory Depression (Opioid Toxicity): In severe overdosage, the Diphenoxylate component acts as a full systemic opioid, causing profound central nervous system depression, coma, and fatal respiratory arrest. This is particularly dangerous in young children; use is strictly contraindicated in children under 6 years of age.
• Severe Anticholinergic Toxicity: Due to the Atropine component, overdose will trigger a violent anticholinergic crisis (flushing, hyperthermia, tachycardia, and urinary retention).
• Hepatic Impairment: Must be used with extreme caution in patients with advanced hepatorenal disease, as hepatic coma may be precipitated.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Acute Care Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antidiarrheals, Opioid-Receptor Agonists, and Extreme Microdose Content-Uniformity Assured Formulations. Whether you are looking for a reliable Government Tender Supplier for infectious disease wards in Africa or a B2B Pharma Marketplace partner for the CIS, our highly regulated logistics network ensures timely, fully compliant delivery of WHO-GMP certified products.